Global artificial intelligence (AI) in oncology market is anticipated to grow at a CAGR of 32.6 % during the forecast period (2023-2030). Medical imaging analysis using AI is used to analyze medical images including X-rays, CT scans, MRIs, PET scans, and histopathology slides. It can help detect and characterize tumors, lesions, and abnormalities, in addition to identifying cancerous cells and tissue patterns. AI can additionally be used to analyze genomic data and determine how a patient's genetic makeup affects their response to specific cancer drugs. Furthermore, AI can be used to create precise radiation therapy treatment plans, tailor chemotherapy regimens, identify the most suitable targeted therapies, and match cancer patients with suitable clinical trials. The market’s growth is attributed to data quality and accessibility. Utilizing electronic health records (EHRs) and platforms such as Vista, a significant amount of real-world, high-quality patient data can be collected. For developing insights into cancer treatment and training AI models, a comprehensive dataset is essential. For instance, in October 2023, COTA launched a new real-world data platform to accelerate cancer research and advance generative AI models in oncology. To promote real-world evidence (RWE) insights in oncology and to open the door for the development of trusted generative AI in cancer care, Vista was developed employing automation to speed up and, consequently, scale up EHR data abstraction.
Browse the full report description of “Artificial Intelligence (AI) In Oncology Market Size, Share & Trends Analysis Report By Component (Software, Hardware, And Services), By Cancer Type (Breast, Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, And Others), By Treatment Type (Into Chemotherapy, Radiation Therapy, Immunotherapy, And Others), And By Application (Cancer Detection, Drug Discovery, Drug Development, And Others), Forecast Period (2023-2030)” at https://www.omrglobal.com/industry-reports/intelligence-ai-in-oncology-market
Furthermore, AI platforms such as Tara make use of a wide range of data sources, including electronic health records and genomic information. This has contributed to the increased importance of real-world data and real-world evidence in cancer research and treatment. in September 2023, Belong.Life launched Tara - an AI SaaS matching cancer patient to clinical trials. The Tara platform, aimed toward medical professionals and contract research organizations (CROs), was designed to accelerate the process of matching individuals with clinical trials that are appropriate for individuals.
Market Coverage
• The market number available for – 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Component
o By Cancer Type
o By Treatment Type
o By Application
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- Amazon Web Service, Inc., Google, LLC, IBM Corp., Intel Corp., Microsoft Corp., and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Artificial Intelligence (AI) in Oncology Market Report Segment
By Component
By Cancer Type
By Treatment Type
Global Artificial Intelligence (AI) in Oncology Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/intelligence-ai-in-oncology-market